Scientific Presentations – Outliers – UW–Madison
Responding at patient's time of need: Scaling rapid access to evidence based treatment plan – Navya Blog
2023 American Association For Cancer Research Annual, 49% OFF
AACR BluePrint HER2 Poster 2612 - Agendia
ex99-1_004.jpg
2018 SABCS FLEX Trials in Progress Poster - Agendia
Posters — Creatv BIO
Resource Library
Kelsey and Keighley present at SABCS | Taube Lab
Kelsey and Keighley present at SABCS | Taube Lab
San Antonio Breast Cancer Symposium > Home
Resource Library
2018 SABCS online resource library now available - Blogs
Resource Library
HR+/HER2- Advanced breast cancer: what are the latest developments in CDK4/6 inhibition from the SABCS 2019? - touchONCOLOGY
San Antonio Breast Cancer Symposium (SABCS) 2018! - Lee/Oesterreich Laboratory
JCEMS-Call for poster abstracts | PDF
MagSense® Pre-Clinical Study Presented at 2018 SABCS | Imagion Biosystems
KETOROLAC poster presented at the San Antonio Breast Cancer Symposium | Anticancerfund
2018 SABCS FLEX Trials in Progress Poster - Agendia
SABCS 2018
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS | Business Wire
![I-SPY2 Presentations and Posters at SABCS 2018 [I-SPY Trials]](https://assets-global.website-files.com/5acff833a26e51b82579a916/5bf5f8284fac8068996a2540_SABCS-crowd-shot2.jpg "I-SPY2 Presentations and Posters at SABCS 2018 [I-SPY Trials]")
I-SPY2 Presentations and Posters at SABCS 2018 [I-SPY Trials]
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire
